[Nasal hyperreactivity. Pharmacodynamics].
D002217:Carbachol / Q000494:pharmacology; D002648:Child; D002675:Child, Preschool; D006801:Humans; D009241:Ipratropium / Q000627:therapeutic use; D008173:Lung Diseases, Obstructive / Q000188:drug therapy / Q000503:physiopathology; D016210:Methacholine Chloride; D008688:Methacholine Compounds / Q000494:pharmacology; D009297:Nasal Mucosa / Q000187:drug effects / Q000503:physiopathology*; D009299:Nasal Provocation Tests / Q000379:methods*; D010275:Parasympathetic Nervous System / Q000187:drug effects / Q000503:physiopathology; D011950:Receptors, Cholinergic / Q000187:drug effects; D012220:Rhinitis / Q000188:drug therapy / Q000503:physiopathology
D008688:Methacholine Compounds; D011950:Receptors, Cholinergic; D016210:Methacholine Chloride; D002217:Carbachol; D009241:Ipratropium
Hiperreactividad nasal. Farmacodinámica.